E9Q Stock Overview
An investment holding company, primarily operates private hospitals in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Guangdong Kanghua Healthcare Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.20 |
| 52 Week High | HK$0.30 |
| 52 Week Low | HK$0.003 |
| Beta | 0.62 |
| 11 Month Change | 63.20% |
| 3 Month Change | -17.07% |
| 1 Year Change | 5.15% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| E9Q | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 5.2% | 1.8% | 0.8% |
| 1Y | 5.2% | 17.4% | 9.1% |
Return vs Industry: E9Q underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: E9Q underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| E9Q volatility | |
|---|---|
| E9Q Average Weekly Movement | 1,989.7% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: E9Q's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: E9Q's weekly volatility has increased from 1015% to 1990% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4,231 | Wangzhi Chen | www.kanghuagp.com |
Guangdong Kanghua Healthcare Group Co., Ltd., an investment holding company, primarily operates private hospitals in the People’s Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services.
Guangdong Kanghua Healthcare Group Co., Ltd. Fundamentals Summary
| E9Q fundamental statistics | |
|---|---|
| Market cap | €76.28m |
| Earnings (TTM) | €6.71m |
| Revenue (TTM) | €269.07m |
11.4x
P/E Ratio0.3x
P/S RatioIs E9Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E9Q income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.72b |
| Gross Profit | CN¥319.78m |
| Other Expenses | CN¥268.91m |
| Earnings | CN¥50.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 15.68% |
| Net Profit Margin | 2.49% |
| Debt/Equity Ratio | 17.3% |
How did E9Q perform over the long term?
See historical performance and comparison